70 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
voting rights.
In connection with the execution of the Acquisition Agreement, Spyre and Pre-Merger Spyre entered into stockholder support agreements … of Series B Non-Voting Convertible Preferred Stock (“Series B Certificate of Designation”), the Series B Preferred Stock does not have voting rights
424B3
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Prospectus supplement
4:06pm
actually paid on shares of the Common Stock. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However
8-K
SYRE
Spyre Therapeutics Inc.
18 Mar 24
Spyre Therapeutics Announces $180 Million Private Placement
8:31am
on shares of the Common Stock. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any
POS AM
gif2a4fx 7m
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
POS AM
jism33o 40nwxsxeds
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
424B3
mw8nbg0
6 Feb 24
Prospectus supplement
9:37pm
8-K
EX-3.1
codlehnb 1wk
5 Feb 24
Entry into a Material Definitive Agreement
7:36am